MeSH D004761 - pseudomembranous enterocolitis
Favorite
Competitive Landscape
Events Timeline
Commercial
Clinical Trials
Competitive landscape
Events Timeline
Commercial
Company Name | Drug Name | Trade Name | Patent Expires | Approval Date | Revenue | Period |
|---|---|---|---|---|---|---|
| Teva | Metronidazole | Metronidazole |  | 1984-11-06 |  |  |
| Vancomycin | Vancomycin |  | 2015-12-23 |  |  | |
| Metronidazole | Vandazole | 2024-09-22 | 2005-05-20 |  |  | |
| Padagis | Metronidazole | Metronidazole |  | 2019-07-02 |  |  |
| Taro Pharmaceutical | Metronidazole | Metronidazole |  | 2006-07-18 |  |  |
| Glenmark Pharmaceuticals | Metronidazole | Metronidazole |  | 2022-01-27 |  |  |
| Mylan | Vancomycin | Vancomycin |  | 2008-12-30 |  |  |
| Johnson & Johnson | Metronidazole | Protostat |  | 1983-03-02 |  |  |
| Lupin Research | Metronidazole | Metronidazole |  | 2017-09-12 |  |  |
| Vancomycin | Vancomycin |  | 2015-01-28 |  |  | |
| Sandoz | Vancomycin | Vancomycin |  | 2010-04-27 |  |  |
1
2
3
4
5
6
...
10
>
Clinical Trials
Historical Success Rate
Phase 1
0%0/0
Phase 2
100%1/1
Phase 3
80%8/10
Approved: 7Overall Success rate: 0%
All Clinical Trials
Therapeutic Areas:
All
Classification:
All
Approval:
All
Status:
All
Phases:
All
Company name | Phase 1 | Phase 2 | Phase 3 | Phase 4 | Drug Name |
|---|---|---|---|---|---|
1
2
3
4
5
6
7
>
© 2020-2025 Collaborative Drug Discovery Inc. (CDD) | Terms of Use